微信直播

Hisao Asamura: 肺段研究JCOG802有哪些值得期待?

Published at: 2015年第1卷第S1期

王嘉慧
关键词:

编者按:第四届东方胸外科论坛于5月12日在上海复旦大学中山医院圆满举办。来自国内外的胸外科专家,就肺外科、食管外科、纵膈、气管、移植外科、转化医学和新技术、胸外科并发症等话题展开讨论。来自日本庆应义塾大学医院的Hisao Asamura(浅村尚生)教授在大会中发表题为 ”Segmentectomy for lung cancer: a key note speech” 的演讲。他从肺癌手术的演变讲起,结合大量实验进行分析,为学者全面介绍了肺段切除术在治疗肺癌的应用及发展。

会议间隙,AME出版社有幸邀请到Asamura教授进行专访。(图1)Asamura教授带领其团队开展了一项大型前瞻性随机临床实验——JCOG802,旨在探讨肺叶切除和肺段切除两种方法,哪一种对于可手术切除的非小细胞肺癌有效。谈及围手术期的手术并发症,Asamura教授说,无论是肺段切除还是肺叶切除,都是常规手术,因而伴随的并发症都是普遍会遇到的,包括持续性漏气等。但他认为这些并发症都在可控范围内。第18届世界肺癌大会将于今年十月在日本召开。作为本届大会主席,Asamura教授特别提到,过去两年肺癌领域发展很快,特别是在肺癌的免疫治疗方面;除此之外,肺癌分子靶向治疗领域也有很多进展。今年的大会将会围绕这些最新的进展展开讨论,欢迎更多的肺癌领域同道参会。

图1. Hisao Asamura(浅村尚生)教授与采访编辑合影

采访问题:

  1. We know you are now leading the big clinical trial the JCOG802. We are particularly interested in this trial. Would you mind giving us a general picture of this trial?

  2. According to this trial, what’s the main complication during perioperative period? What's your experience to handle the complication?

  3. What initially inspired you to start this clinical trial? Are there any stories that can be shared here?

  4. What do you think of minimally invasive surgery? In your opinion, what is the challenge for minimally invasive thoracic surgery currently?

  5. The 18th World Conference on Lung Cancer (WCLC) will be held in Japan in October 2017. As the president, what do you think we could expect from this year’s conference?

受访专家:

Hisao Asamura, MD, is chief of thoracic surgery at the National Cancer Center Hospital in Tokyo, Japan. His research interests include thoracic surgery. Dr. Asamura earned his undergraduate and medical degrees at Keio University. His specialty is thoracic surgery.

采访编辑:王嘉慧,AME Publishing Company.

视频剪辑:麦雪芳,AME Publishing Company.

comments powered by Disqus

附件